IL-22结合蛋白缺失增加脓毒症肠道通透性、菌群失调与死亡率
该研究采用盲肠结扎穿孔(CLP)脓毒症小鼠模型,比较野生型、IL-22缺陷(Il22-/-)和IL-22BP缺陷(Il22ra2-/-)小鼠。CLP后血浆和空肠IL-22及血浆IL-22BP均显著升高。Il22-/-小鼠死亡率和肠道通透性与野生型无显著差异;而Il22ra2-/-小鼠死亡率显著增高(85% vs 40%),肠道通透性增加,伴claudin-4升高、claudin-15降低及局部细胞因子上调,组织学无差异。基线及CLP后24小时菌群组成有差异,同笼饲养消除生存差异。提示IL-22BP在脓毒症中维持肠道稳态起保护作用。
要点
- Il22ra2-/-小鼠CLP后死亡率显著高于野生型(85% vs 40%),肠道通透性增加。
- Il22-/-小鼠CLP后死亡率及肠道通透性与野生型无显著差异。
- Il22ra2-/-小鼠伴claudin-4表达升高、claudin-15表达降低及局部细胞因子上调,组织学无差异。
- 野生型与Il22ra2-/-小鼠粪便细菌载量相当,但基线及CLP后24小时菌群组成不同。
- 同笼饲养消除两组间生存差异,提示菌群或环境因素介导该表型。
适用人群与场景
- 盲肠结扎穿孔(CLP)脓毒症小鼠模型, sham对照;非人类临床人群。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:动物实验(小鼠CLP模型);样本量与中心数原文未提及。
- 干预与对照:比较Il22-/-、Il22ra2-/-与野生型小鼠,设sham对照。
- 主要终点结果:Il22ra2-/-小鼠死亡率85% vs 野生型40%,肠道通透性增加;Il22-/-与野生型无显著差异。
- 关键次要终点:Il22ra2-/-小鼠claudin-4升高、claudin-15降低、局部细胞因子上调,组织学无差异;粪便细菌载量相当但菌群组成不同;同笼饲养消除生存差异。
证据类型、等级与局限
- 证据类型:动物实验(小鼠模型);证据等级或推荐强度原文未提及;局限:动物模型结果不能直接外推至临床,样本量原文未提及。
对床旁实践的改变
- 原文未提及
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The gut is hypothesized to play a pivotal role in sepsis progression through increased intestinal permeability, dysbiosis, and immune dysregulation. Interleukin (IL)-22 maintains intestinal homeostasis and is negatively regulated by IL-22 binding protein (IL-22BP), yet the roles of IL-22 and IL-22BP in sepsis remain undetermined. Using a cecal ligation and puncture (CLP) model with a sham control, we measured IL-22 and IL-22BP at 24 h and compared IL-22-deficient (Il22-/-) and IL-22BP-deficient (Il22ra2-/-) mice with wild-type (WT) mice. Gut permeability, tight junction protein expression, histology, and cytokines were assessed at 24 and 48 h, and the microbiome at baseline and 24 h. Survival was monitored for 168 h; co-housed mice were also evaluated. Plasma and jejunal IL-22, along with plasma IL-22BP levels, were significantly higher in CLP than in sham mice. In Il22-/- mice, mortality and gut permeability showed no significant difference from those in WT mice. By contrast, Il22ra2-/- mice exhibited significantly higher mortality (85% vs. 40%) and increased gut permeability. These changes were associated with elevated claudin-4 and reduced claudin-15 expression, localized cytokine upregulation, and no histological differences. Fecal bacterial loads were comparable between WT and Il22ra2-/- mice, but microbiome composition differed at baseline and 24 h after CLP. Co-housing eliminated the survival difference between groups. In conclusion, whereas IL-22 deficiency had no impact on gut permeability or mortality, IL-22BP deficiency increased gut permeability and mortality with altered cytokine expression and gut dysbiosis, suggesting that IL-22BP plays a protective role in maintaining gut homeostasis in sepsis.
参考来源
- Miyauchi S, Oami T, Satoh-Takayama N, et al. Deletion of interleukin-22 binding protein increases gut permeability, dysbiosis, and mortality in sepsis. Shock. 2026. PMID: 42752565. doi:10.1097/SHK.0000000000002942
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。